0001605096-18-000001.txt : 20180514 0001605096-18-000001.hdr.sgml : 20180514 20180514091924 ACCESSION NUMBER: 0001605096-18-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180514 DATE AS OF CHANGE: 20180514 EFFECTIVENESS DATE: 20180514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioClin Therapeutics, Inc. CENTRAL INDEX KEY: 0001605096 IRS NUMBER: 273630029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-282960 FILM NUMBER: 18828915 BUSINESS ADDRESS: STREET 1: 130 MARKET PLACE, PMB #295 CITY: SAN RAMON STATE: CA ZIP: 94583 BUSINESS PHONE: 925-413-6140 MAIL ADDRESS: STREET 1: 130 MARKET PLACE, PMB #295 CITY: SAN RAMON STATE: CA ZIP: 94583 D/A 1 primary_doc.xml X0708 D/A LIVE 0001605096 BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 925-413-6140 DELAWARE None None Corporation true Stephen W. Lau c/o BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Executive Officer Director President, Chief Executive Officer, and Treasurer Joseph L. Turner c/o BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Director Marten Steen c/o BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Director Fouad Azzam c/o BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Director Christian Richard c/o BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Director Joel Jean-Mairet c/o BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Director David Kabakoff c/o BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Director Steve Abella BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Executive Officer Chief Medical Officer Graeme Currie BioClin Therapeutics, Inc. 1040 Davis Street #202 San Leandro CA CALIFORNIA 94577 Executive Officer Chief Operating Officer Biotechnology Decline to Disclose 06b true 0001605096-17-000002 2017-03-06 false true false 0 50003996 50003996 0 Offer and Sale of Series B Preferred Stock (and the shares issuable thereunder) and Special Voting Series B Preferred false 9 0 0 0 false BioClin Therapeutics, Inc. Stephen W. Lau Stephen W. Lau President & CEO 2018-05-08